2024-05-28 RXST looks bullishRXST has a pretty good EPS and Sale growth. Consolidate into a tight base and looks like ready to go higher.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.82 USD
−48.61 M USD
89.08 M USD
37.66 M
About RxSight, Inc.
Sector
Industry
CEO
Ronald M. Kurtz
Website
Headquarters
Aliso Viejo
Founded
1997
FIGI
BBG00THX1YN4
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.
RxSight Unveils Light Adjustable Lens for Cataract SurgeryRxSight, Inc., ( NASDAQ:RXST ) a trailblazing ophthalmic medical device company, has set its sights on revolutionizing cataract surgery with the commercial launch of its latest innovation, the Light Adjustable Lens+™ (LAL+). This pioneering lens, alongside its predecessor the LAL®, promises to deliv
Breakout w/ no tighteningCould be a breakout that was breaking above resistance around the $40.60 area. Not really liking how it never had any meaningful tightening like it did earlier around May / July of this year. As usual trend is up so we attempt to go along with it. We'll leave it to probability and let it sort itself
$RXST looking to head higher?Notes:
* Coming up on the right side of its base
* Volume increasing with price
* Two levels of resistance at which we can take partial profits.
Technicals:
Ticker: $RXST
Sector: Healthcare - Medical Devices
Relative Strength vs. Sector: 25.97
Relative Strength vs. SP500: 8.57
U/D Ratio: 1.7
Bas
$RXST is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $18,06;
stop-loss — $1
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RXST is 48.01 USD — it has decreased by −5.59% in the past 24 hours. Watch RxSight, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange RxSight, Inc. stocks are traded under the ticker RXST.
RXST stock has fallen by −6.23% compared to the previous week, the month change is a −2.89% fall, over the last year RxSight, Inc. has showed a 92.73% increase.
We've gathered analysts' opinions on RxSight, Inc. future price: according to them, RXST price has a max estimate of 70.00 USD and a min estimate of 56.00 USD. Watch RXST chart and read a more detailed RxSight, Inc. stock forecast: see what analysts think of RxSight, Inc. and suggest that you do with its stocks.
RXST reached its all-time high on May 7, 2024 with the price of 66.54 USD, and its all-time low was 8.80 USD and was reached on Jan 7, 2022. View more price dynamics on RXST chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RXST stock is 19.51% volatile and has beta coefficient of 1.05. Track RxSight, Inc. stock price on the chart and check out the list of the most volatile stocks — is RxSight, Inc. there?
Today RxSight, Inc. has the market capitalization of 1.94 B, it has increased by 3.31% over the last week.
Yes, you can track RxSight, Inc. financials in yearly and quarterly reports right on TradingView.
RxSight, Inc. is going to release the next earnings report on Mar 11, 2025. Keep track of upcoming events with our Earnings Calendar.
RXST earnings for the last quarter are −0.16 USD per share, whereas the estimation was −0.25 USD resulting in a 35.03% surprise. The estimated earnings for the next quarter are −0.17 USD per share. See more details about RxSight, Inc. earnings.
RxSight, Inc. revenue for the last quarter amounts to 35.31 M USD, despite the estimated figure of 35.06 M USD. In the next quarter, revenue is expected to reach 40.30 M USD.
RXST net income for the last quarter is −6.34 M USD, while the quarter before that showed −6.08 M USD of net income which accounts for −4.26% change. Track more RxSight, Inc. financial stats to get the full picture.
No, RXST doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 374.00 employees. See our rating of the largest employees — is RxSight, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RxSight, Inc. EBITDA is −34.90 M USD, and current EBITDA margin is −51.46%. See more stats in RxSight, Inc. financial statements.
Like other stocks, RXST shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RxSight, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RxSight, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RxSight, Inc. stock shows the neutral signal. See more of RxSight, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.